Digital intelligent diagnostic and treatment technology is a novel technology which is based by combining modern medicine with digitalized and intelligent high-tech to form a multidisciplinary and multi-knowledge domain. This technology plays an important role in areas including precision diagnosis, preoperative planning and surgical navigation. Its core technologies are: (1) quality control research on high-quality CT imaging data acquisition; (2) quality control and homogenization research on three-dimensional (3D) reconstruction; (3) high-quality 3D printed physical models; (4) virtual reality 3D simulation platform; (5) molecular fluorescence imaging to define tumor boundaries; (6) non-rigid registration multi-mode image fusion surgical navigation system; (7) image feature extraction and prediction model establishment. The workflow of this system includes: First, CT data acquisition and 3D visualization of hepatobiliary and pancreatic diseases; followed by individualized vascular assessment, liver volume calculation and surgical planning using the 3D model; then virtual simulation surgery, 3D printing, virtual reality technology and molecular fluorescence imaging accordance to the required specific conditions. Preoperative radiomics are used to predict the risk of complications and long-term follow-up results. Intraoperative multi-modal fusion image navigation and its consistency are evaluated with the findings in actual surgery and preoperative planning. This technology, hopefully, will bring in novel strategies and approaches in the diagnosis and treatment of hepatobiliary and pancreatic diseases.
数字智能化诊疗技术是以现代医学和数字化、智能化高新技术相结合为基础,涵盖了多学科和多领域知识所形成的新型诊疗技术,为疾病精确诊断、术前规划、手术导航等发挥了重要作用。其核心技术如下:(1)高质量CT图像数据采集的质控化研究;(2)三维重建质控化、同质化研究;(3)高质量的三维打印技术;(4)虚拟现实三维仿真平台;(5)分子荧光成像肿瘤边界界定;(6)非刚性配准多模态图像融合手术导航;(7)影像组学特征提取及预测模型的建立。其体系流程如下;肝胆胰疾病CT数据采集和三维可视化处理,基于三维模型的个体化血管评估、肝体积计算和手术规划,针对具体情况进行虚拟仿真手术、三维打印、虚拟现实技术和分子荧光成像。术前采用影像组学预测并发症发生风险及术中多模态融合图像导航,实际手术与术前规划一致性评估,术后定期随访。数字智能化诊疗技术为肝胆胰疾病的精准诊疗带来了新的策略和手段,实现了肝胆胰外科的解剖数字化、诊疗智能化和手术精准化。.
Keywords: Biliary tract neoplasms; Digital medicine; Intelligent; Liver neoplasms; Pancreatic neoplasms; Treatment technology.